Cure Parkinson's

cureparkinsons.org.uk

01 October 2026 21:28

Results from Exenatide-PD3 sub-study, funded by Cure Parkinson’s, reveal a new way to predict Parkinson’s progression. Exenatide-PD3 was a phase 3 clinical trial of the Type 2 diabetes drug exenatide (Bydureon) which finished in early 2024. Find out more about the study: buff.ly/AjR8rjO

Cure Parkinson's

cureparkinsons.org.uk

25 September 2026 08:38

Missed our Parkinson’s and dementia webinar? You can now catch up with the recording, featuring Edinburgh University’s Professor Tilo Kunath and an expert panel discussing the relationship between Parkinson’s and dementia. Watch now: buff.ly/0G5VXkR

MS Society UK

mssocietyuk.bsky.social

25 September 2026 08:34

😁 We were very excited to announce the interim results of our Octopus trial earlier this month, and the result that alpha-lipoic acid showed early promise as a treatment for progressive #multiplesclerosis.

Erin Williams, Ph.D.

erinwilliamsphd.bsky.social

08 September 2026 17:41

Thanks for the highlight, Simon!

Dr Poonam Thakur

poonamthakur.bsky.social

31 August 2026 15:40

Happy to share our new publication in Molecular Neurobiology! Coffee and its compounds have been linked to neuroprotection in several neurodegenerative diseases. Chlorogenic acid (CA), a coffee-derived compound, has also shown promise in preclinical studies. link.springer.com/article/10.1...